Company Profile
Bellco Capital is a Los Angeles-based single-family office established in 2003 by Rebecka Belldegrun, M.D. and Arie Belldegrun, M.D., FACS. The firm manages the wealth of the Belldegrun family and operates as a direct investment firm focused on deploying capital to create and support companies with bold ambitions of exponential transformation.
Bellco Capital invests across life sciences, real estate, consumer products, media, and other sectors. The firm is particularly known for its deep expertise in biotechnology and therapeutics. Arie Belldegrun is renowned for founding Kite Pharma, which was sold in 2017 for approximately $11.9 billion, and co-founding Allogene Therapeutics.
Notable investments include Kite Pharma, Allogene Therapeutics, Agensys, ByHeart, Cell Design Labs, Cougar Biotechnology, First Media, Hubble, Kronos Bio, Neogene, and UroGen Pharma. The firm allocates across real estate, private equity, direct investments, life sciences, and venture capital.
News & Signals (0)
No linked news activity found for this company.